Julian Desgrippes

Head of Business Development Licensing, Medical Care at Pierre Fabre Group

Speaker

Julien has joined Pierre Fabre S.A. Business Development Team since November 2016. He has been working since then on a range of partnering opportunities and transactions to strengthen Pierre Fabre’s portfolio as well as to value internal R&D programs externally. His scope of interest encompasses R&D and commercial assets, within three therapeutic areas of focus: Oncology, Medical Dermatology and Rare Diseases. He has been directly involved in most of Pierre Fabre recent Business Development activities (Atara Biotherapeutics, Puma Biotechnology, CANbridge, Talem Therapeutics, Valenza Bio, Y Biologics etc.).

Before joining Pierre Fabre, Julien was working with AEC Partners, a strategic consulting and M&A boutique specialized in healthcare based in Paris France. He worked on several assignments across the world, not only related to the evaluation and valuation of assets and markets but also working on commercial and organizational problematics. His clients were large pharmaceutical companies, biotech, medtech, animal health or nutrition companies.

Julien holds a Master of Science from HEC Paris, and is a Doctor of Pharmacy from Lyon 1 University.